Attached files
file | filename |
---|---|
10-K - 10-K - Krystal Biotech, Inc. | krys-10k_20191231.htm |
EX-32.1 - EX-32.1 - Krystal Biotech, Inc. | krys-ex321_7.htm |
EX-32.2 - EX-32.2 - Krystal Biotech, Inc. | krys-ex322_10.htm |
EX-10.13 - EX-10.13 WHARTON LEASE 3RD AMENDMENT - Krystal Biotech, Inc. | krys-ex1013_80.htm |
EX-23.1 - EX-23.1 - Krystal Biotech, Inc. | krys-ex231_8.htm |
EX-31.1 - EX-31.1 - Krystal Biotech, Inc. | krys-ex311_9.htm |
EX-4.3 - EX-4.3 DESCRIPTION OF COMMON STOCK - Krystal Biotech, Inc. | krys-ex43_128.htm |
EX-10.14 - EX-10.14 WHARTON LEASE 4TH AMENDMENT - Krystal Biotech, Inc. | krys-ex1014_79.htm |
EX-31.2 - EX-31.2 - Krystal Biotech, Inc. | krys-ex312_11.htm |
EX-10.16 - EX-10.16 ASTRA LEASE - Krystal Biotech, Inc. | krys-ex1016_82.htm |
EX-10.15 - EX-10.15 WHARTON LEASE 5TH AMENDMENT - Krystal Biotech, Inc. | krys-ex1015_81.htm |
Exhibit 21.1
SUBSIDIARIES OF KRYSTAL BIOTECH, INC. AS OF DECEMBER 31, 2019
Name |
|
Direct Parent |
|
Ownership |
|
|
Jurisdiction of Incorporation |
Krystal Australia Pty Ltd |
|
Krystal Biotech, Inc. |
|
100% |
|
|
Australia |
Jeune, Inc. |
|
Krystal Biotech, Inc. |
|
100% |
|
|
Delaware |